PGAM1-CHK1 interaction inhibitor

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Funders: Core Research for Evolutional Science and Technology and 4 more
  • Animals1

Outcomes

3

Physical function

upin mice1

1 study
  1. PGAM1-CHK1 interaction inhibitor improves physical function in mice.

    “Inhibition of the PGAM1-Chk1 interaction improves physiological parameters during aging and inhibits lung fibrosis in mouse models.”

    Animalsduring aging

    Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions

    Signal transduction and targeted therapy15 Dec 2025

Pulmonary fibrosis

downin mice1

1 study
  1. PGAM1-CHK1 interaction inhibitor decreases pulmonary fibrosis in mice.

    “Inhibition of the PGAM1-Chk1 interaction improves physiological parameters during aging and inhibits lung fibrosis in mouse models.”

    Animalsin mouse models

    Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions

    Signal transduction and targeted therapy15 Dec 2025

More on Pulmonary fibrosis

Cellular senescence

downin mice1

1 study
  1. PGAM1-CHK1 interaction inhibitor decreases cellular senescence in mice.

    “Chemical abrogation of PGAM1-Chk1 binding reverts these phenotypes and eliminates SnCs through senolysis.”

    Animalschemical abrogation of PGAM1-Chk1 binding

    Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions

    Signal transduction and targeted therapy15 Dec 2025

More on Cellular senescence

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months